List of SBIR/STTR awards granted to NanoValent Pharmaceuticals, Inc.

List of SBIR/STTR awards granted to NanoValent Pharmaceuticals, Inc.

List of SBIR/STTR awards granted to LIGHTLINE TECHNOLOGIES INC

List of SBIR/STTR awards granted to Glucosentient, Inc.

List of SBIR/STTR awards granted to MB Research Laboratories

Companies in the Electric vehicle battery test equipment industry

List of companies in Flyover Capital's investment portfolio

where

SBIR/STTR Award Recipient

is

‌

NanoValent Pharmaceuticals, Inc.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ NanoValent Pharmaceuticals, Inc. SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to NanoValent Pharmaceuticals, Inc. in September, 2018 for $1,590,480.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NanoValent Pharmaceuticals, Inc.		National Institutes of Health	SBIR	2R44GM116530-02	Phase II	1,590,480	September 1, 2018	sbir.gov/node/1571421
	‌ NanoValent Pharmaceuticals, Inc. SBIR Phase II Award, May 2019	A SBIR Phase II contract was awarded to NanoValent Pharmaceuticals, Inc. in May, 2019 for $1,019,254.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NanoValent Pharmaceuticals, Inc.		National Institutes of Health	SBIR	4R44CA233128-02	Phase II	1,019,254	May 1, 2019	sbir.gov/node/1685993
	‌ NanoValent Pharmaceuticals, Inc. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to NanoValent Pharmaceuticals, Inc. in September, 2018 for $240,749.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NanoValent Pharmaceuticals, Inc.		National Institutes of Health	SBIR	1R44CA233128-01	Phase I	240,749	September 14, 2018	sbir.gov/node/1570663
	‌ NanoValent Pharmaceuticals, Inc. STTR Phase I Award, February 2016	A STTR Phase I contract was awarded to NanoValent Pharmaceuticals, Inc. in February, 2016 for $238,728.0 USD from the U.S. Department of Health & Human Services.	‌ NanoValent Pharmaceuticals, Inc.			STTR	1R41GM116530-01A1	Phase I	238,728	February 1, 2016	sbir.gov/node/1162815
	‌ NanoValent Pharmaceuticals, Inc. STTR Phase I Award, April 2016	A STTR Phase I contract was awarded to NanoValent Pharmaceuticals, Inc. in April, 2016 for $240,750.0 USD from the U.S. Department of Health & Human Services.	‌ NanoValent Pharmaceuticals, Inc.			STTR	1R41CA203457-01A1	Phase I	240,750	April 15, 2016	sbir.gov/node/1162481
	‌ NanoValent Pharmaceuticals, Inc. SBIR Phase II Award, October 2013	A SBIR Phase II contract was awarded to NanoValent Pharmaceuticals, Inc. in October, 2013 for $300,000.0 USD from the National Science Foundation.	‌ NanoValent Pharmaceuticals, Inc.	National Science Foundation		SBIR	1330140	Phase II	300,000	October 1, 2013	sbir.gov/node/682966
	‌ NanoValent Pharmaceuticals, Inc. SBIR Phase I Award, January 2012	A SBIR Phase I contract was awarded to NanoValent Pharmaceuticals, Inc. in January, 2012 for $149,848.0 USD from the National Science Foundation.	‌ NanoValent Pharmaceuticals, Inc.	National Science Foundation		SBIR	1143342	Phase I	149,848	January 1, 2012	sbir.gov/node/391743
	‌ NANOVALENT PHARMACEUTICALS INC STTR Phase I Award, August 2023	A STTR Phase I contract was awarded to NanoValent Pharmaceuticals, Inc. in August, 2023 for $400,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ NanoValent Pharmaceuticals, Inc.		National Institutes of Health	STTR	1R42CA281707-01	Phase I	400,000	August 8, 2023	sbir.gov/node/2503749

8 results

0 selected

8 results

0 selected